The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1
|
---|---|
Published in |
Frontiers in Psychiatry, August 2021
|
DOI | 10.3389/fpsyt.2021.701729 |
Pubmed ID | |
Authors |
Mara Parellada, Antonia San José Cáceres, Melanie Palmer, Richard Delorme, Emily J. H. Jones, Jeremy R. Parr, Evdokia Anagnostou, Declan G. M. Murphy, Eva Loth, Paul P. Wang, Tony Charman, Andre Strydom, Celso Arango |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 31% |
United Kingdom | 3 | 23% |
Spain | 1 | 8% |
Canada | 1 | 8% |
France | 1 | 8% |
Switzerland | 1 | 8% |
Unknown | 2 | 15% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 54% |
Scientists | 3 | 23% |
Practitioners (doctors, other healthcare professionals) | 3 | 23% |
Mendeley readers
The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 74 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 9% |
Researcher | 6 | 8% |
Unspecified | 5 | 7% |
Student > Bachelor | 5 | 7% |
Student > Doctoral Student | 4 | 5% |
Other | 9 | 12% |
Unknown | 38 | 51% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 9 | 12% |
Unspecified | 5 | 7% |
Medicine and Dentistry | 5 | 7% |
Social Sciences | 5 | 7% |
Nursing and Health Professions | 2 | 3% |
Other | 5 | 7% |
Unknown | 43 | 58% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2022.
All research outputs
#6,613,465
of 25,909,281 outputs
Outputs from Frontiers in Psychiatry
#3,131
of 12,929 outputs
Outputs of similar age
#124,281
of 437,475 outputs
Outputs of similar age from Frontiers in Psychiatry
#144
of 617 outputs
Altmetric has tracked 25,909,281 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 12,929 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,475 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 617 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.